Ignite Creation Date:
2025-12-24 @ 11:44 PM
Ignite Modification Date:
2025-12-26 @ 4:49 PM
Study NCT ID:
NCT00015951
Status:
COMPLETED
Last Update Posted:
2019-10-17
First Post:
2001-05-06
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Bevacizumab, Cytarabine, and Mitoxantrone on Treating Patients With Hematologic Cancers
Sponsor:
University of Maryland, Baltimore
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
CDR0000068576
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
None
Old Organization:
UM Greenebaum Cancer Center